TransMedics Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade TransMedics Group 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About TMDX
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform.
CEOWaleed H. Hassanein
CEOWaleed H. Hassanein
Employees728
Employees728
HeadquartersAndover, Massachusetts
HeadquartersAndover, Massachusetts
Founded1998
Founded1998
Employees728
Employees728
TMDX Key Statistics
Market cap4.04B
Market cap4.04B
Price-Earnings ratio50.48
Price-Earnings ratio50.48
Dividend yield—
Dividend yield—
Average volume1.25M
Average volume1.25M
High today$122.97
High today$122.97
Low today$115.21
Low today$115.21
Open price$122.97
Open price$122.97
Volume593.51K
Volume593.51K
52 Week high$145.50
52 Week high$145.50
52 Week low$55.00
52 Week low$55.00
Stock Snapshot
As of today, TransMedics Group(TMDX) shares are valued at $118.15. The company's market cap stands at 4.04B, with a P/E ratio of 50.48.
On 2025-11-07, TransMedics Group(TMDX) stock moved within a range of $115.21 to $122.97. With shares now at $118.15, the stock is trading +2.6% above its intraday low and -3.9% below the session's peak.
Trading volume for TransMedics Group(TMDX) stock has reached 593.51K, versus its average volume of 1.25M.
The stock's 52-week range extends from a low of $55.00 to a high of $145.50.
The stock's 52-week range extends from a low of $55.00 to a high of $145.50.
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
23.1%
Sell
0%
People also own
Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.